Searched over 200M research papers
10 papers analyzed
These studies suggest that diabetes has a genetic component, with various genetic variants influencing the risk and progression of both type 1 and type 2 diabetes.
18 papers analyzed
20 papers analyzed
Diabetes mellitus, commonly referred to as diabetes, is a chronic metabolic disorder characterized by high blood sugar levels. It is a significant public health issue globally, with Type 2 diabetes (T2D) being the most prevalent form, accounting for over 90% of cases worldwide. Unlike monogenic disorders, T2D is multifactorial, involving a complex interplay of genetic and environmental factors.
Recent advancements in genome-wide association studies (GWAS) have significantly enhanced our understanding of the genetic underpinnings of T2D. These studies have identified numerous common genetic variants associated with T2D, although these variants collectively explain only a fraction of the disease's heritability. For instance, a large-scale meta-analysis involving over 34,000 cases and 114,000 controls identified ten new T2D susceptibility loci, highlighting the role of various biological processes such as CREBBP-related transcription and adipocytokine signaling in diabetes pathogenesis.
While common variants have been extensively studied, the role of rare genetic variants in T2D is also being explored. However, large-scale sequencing studies suggest that lower-frequency variants do not play a major role in T2D predisposition. Instead, most associated variants are common and fall within regions previously identified by GWAS.
Trans-ethnic meta-analyses have further broadened our understanding by identifying genetic loci that are consistent across different ancestry groups. These studies have revealed a significant excess in the directional consistency of T2D risk alleles across diverse populations, underscoring the genetic overlap in T2D susceptibility.
Type 1 diabetes (T1D) is primarily an immune-mediated disease resulting in the loss of pancreatic beta cells. The genetic landscape of T1D is dominated by the influence of HLA and non-HLA genes, which play crucial roles in disease risk and progression. Recent studies have identified rare genetic variants with large effects on T1D risk, such as a variant in the STK39 gene, which significantly influences disease susceptibility.
Interestingly, some genetic regions are associated with both T1D and T2D, although the direction of effect often differs. For example, variants near the GLIS3 gene increase the risk for both types of diabetes, suggesting shared genetic mechanisms at the pancreatic beta cell level. However, most shared genetic signals have opposite effects on T1D and T2D, indicating a complex genetic relationship between the two diseases.
In summary, both Type 1 and Type 2 diabetes have significant genetic components that contribute to disease susceptibility. Advances in genomic studies, particularly GWAS and trans-ethnic meta-analyses, have identified numerous genetic variants associated with diabetes. Understanding these genetic factors is crucial for developing personalized treatment approaches and improving disease management. Future research will likely focus on integrating genetic data with environmental factors to further elucidate the complex etiology of diabetes.
Most relevant research papers on this topic